Ask AI

Capsule Summaries

Share

Program Content

Activities

  • RASolute 302
    RASolute 302: Phase III Trial of Daraxonrasib vs Chemotherapy in Previously Treated Metastatic Pancreatic Adenocarcinoma
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Incyte Corporation.

Incyte Corporation